Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Enterovirus A type 71 (EV-A71) capsid protein is the outer shell of the virus, composed of VP1, VP2, VP3, and VP4 proteins. It protects the viral genome, mediates attachment to host cell receptors like SCARB2 via VP1, and facilitates uncoating. VP1 is a major target for antiviral drugs that bind its hydrophobic pocket, preventing conformational changes needed for infection. Resistance can emerge through mutations in the VP1 pocket.
Inhibition of capsid conformational changes required for genome release; stabilization of virion
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enterovirus A type 71 Capsid Protein (EV-A71 Capsid).